160 related articles for article (PubMed ID: 20833542)
1. Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.
Xue F; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem Lett; 2010 Nov; 20(21):6258-61. PubMed ID: 20833542
[TBL] [Abstract][Full Text] [Related]
2. 2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.
Kang S; Li H; Tang W; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2015 Jul; 58(14):5548-60. PubMed ID: 26120733
[TBL] [Abstract][Full Text] [Related]
3. The mobility of a conserved tyrosine residue controls isoform-dependent enzyme-inhibitor interactions in nitric oxide synthases.
Li H; Jamal J; Delker S; Plaza C; Ji H; Jing Q; Huang H; Kang S; Silverman RB; Poulos TL
Biochemistry; 2014 Aug; 53(32):5272-9. PubMed ID: 25089924
[TBL] [Abstract][Full Text] [Related]
4. First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.
Cinelli MA; Reidl CT; Li H; Chreifi G; Poulos TL; Silverman RB
J Med Chem; 2020 May; 63(9):4528-4554. PubMed ID: 32302123
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
[TBL] [Abstract][Full Text] [Related]
6. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
7. Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.
Xue F; Fang J; Delker SL; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2011 Apr; 54(7):2039-48. PubMed ID: 21410186
[TBL] [Abstract][Full Text] [Related]
8. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
[TBL] [Abstract][Full Text] [Related]
9. Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.
Cinelli MA; Li H; Chreifi G; Poulos TL; Silverman RB
J Med Chem; 2017 May; 60(9):3958-3978. PubMed ID: 28422508
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Isoform Selective Nitric Oxide Synthase Inhibition by Thiophene-2-carboximidamides.
Li H; Evenson RJ; Chreifi G; Silverman RB; Poulos TL
Biochemistry; 2018 Nov; 57(44):6319-6325. PubMed ID: 30335983
[TBL] [Abstract][Full Text] [Related]
11. Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors.
Jing Q; Li H; Chreifi G; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem Lett; 2013 Oct; 23(20):5674-9. PubMed ID: 23993333
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
13. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
Ji H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2009 Feb; 52(3):779-97. PubMed ID: 19125620
[TBL] [Abstract][Full Text] [Related]
14. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
[TBL] [Abstract][Full Text] [Related]
15. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
Silverman RB
Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
17. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
Boumezber S; Yelekçi K
J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
[TBL] [Abstract][Full Text] [Related]
18. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.
Kang S; Tang W; Li H; Chreifi G; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2014 May; 57(10):4382-96. PubMed ID: 24758147
[TBL] [Abstract][Full Text] [Related]
20. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
